Explore how fed-batch in vitro transcription can improve mRNA yield and reagent utilization and learn how real-time process ...
6d
New mRNA vaccines to be developed, produced in S’pore to develop expertise and prepare for Disease X
Singapore is advancing mRNA influenza vaccine development to boost pandemic preparedness and support global vaccine ...
Moderna (NasdaqGS:MRNA) entered high-level investment talks with the UAE government on advanced pharmaceutical manufacturing ...
The increasingly dynamic and multifaceted landscape of mRNA therapeutics is posing new regulatory and manufacturing challenges. Both startups and established biopharma companies require innovative ...
In recent weeks, Moderna and Merck reported that their Phase 3 INTerpath-001 trial of personalized cancer vaccine intismeran ...
BioNTech recieved a 95 million euro ($110 million) boost from two EU groups that will go toward expanding production of mRNA vaccines in Africa using its modular BioNTainers. (BioNTech) As BioNTech ...
The market for mRNA vaccines has experienced a surge fueled by the global rollout of the COVID-19 vaccines, and the potential of mRNA technology in public health opens a new frontier in medical ...
New center integrates synthetic DNA, mRNA, targeted delivery, and GMP drug product capabilities to help innovators advance genetic medicines from early development through commercial supply Artis ...
FARGO, N.D. & CORALVILLE, Iowa-- (BUSINESS WIRE)--Sep 16, 2026-- ...
An mRNA flu vaccine that updates close to season has finally been approved. Its speed means nothing until officials move a decades-old strain deadline ...
Merck and Moderna announced on August 19 that their personalized mRNA cancer vaccine, intismeran autogene, did something cancer immunologists have been waiting nearly a decade to see: it beat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results